1. Repeated KI prophylaxis in case of prolonged exposure to iodine radioisotopes: pharmacokinetic studies in adult rats
- Author
-
C. Bouvier-Capely, Thibaud Sontag, Alexandre Legrand, Jean-René Jourdain, Valérie Renaud-Salis, David Suhard, Guillaume Phan, Rym Chioukh, Charlotte Moulin, Michelle Agarande, François Rebière, PSE-SANTE/SESANE/LRSI, Institut de Radioprotection et de Sûreté Nucléaire (IRSN), PSE-SANTE, PSE-ENV/SAME, PSE-SANTE/SESUC, Direction des Affaires Etrangères (DAI), and Agence Nationale de la Recherche, ANR ANR-11-RSNR-0019
- Subjects
0301 basic medicine ,Male ,Thyroid Gland ,Pharmaceutical Science ,chemistry.chemical_element ,Administration, Oral ,Pharmacology ,Iodine ,Protective Agents ,Models, Biological ,Permeability ,Iodine Radioisotopes ,03 medical and health sciences ,0302 clinical medicine ,Pharmacokinetics ,pharmacokinetic-pharmacodynamic relationship ,Medicine ,Animals ,Pharmacology (medical) ,Dosing ,Rats, Wistar ,business.industry ,Organic Chemistry ,Thyroid ,Potassium Iodide ,dose regimen ,Potassium iodide prophylaxis ,Effective dose (pharmacology) ,Prolonged exposure ,rats ,Regimen ,030104 developmental biology ,medicine.anatomical_structure ,chemistry ,030220 oncology & carcinogenesis ,[SDV.SP.PHARMA]Life Sciences [q-bio]/Pharmaceutical sciences/Pharmacology ,Molecular Medicine ,Pre-Exposure Prophylaxis ,business ,pharmacokinetics ,Biotechnology - Abstract
International audience; Purpose To propose a new and effective dose regimen for stable potassium iodide (KI) repeated prophylaxis in case ofprolonged exposure to radioactive iodine.Methods The pharmacokinetics of iodine was determined in rats by compartmental analyses after intravenous and oral administrations of the optimal dose of 1 mg/kg KI, which was previously selected in a dose-effect study. The thyroid protection against iodine-125 incorporation was followed during 24 h after a single oral dosing of KI. A repeated KI prophylaxis was modeled using initial estimates of iodine pharmacokinetic parameters.Results A dose regimen consisting in administrations of 1 mg/kg daily for 8 days was selected and studied. Plasma iodine concentrations predicted by simulation were verified by experimental data and varied after the third dose of KIbetween 174 and 1190 μg/l. The inhibition study of iodine-125 binding in the thyroid as a function of the time showedthat the protection effect of KI could be correlated to stable iodine plasma concentrations. Hence, a theoretical decreasein iodine-125 thyroid uptake from 63 to 88% could be achieved in a 24 h-interval between two KI doses.Conclusion Given the satisfactory levels of thyroid protection, this dose regimen could be envisaged in order to extent KI indications for repeated prophylaxis.
- Published
- 2019
- Full Text
- View/download PDF